An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major
Fig 7
Serum cytokine profile of NGP5B and NGP5B+CpG immunizations.
(A-D) Th1 cytokines IL-12p40, IL-2, IFN-γ, and TNF-α. (E-G) Th2 cytokines IL-4, IL-10, and IL-5. (H) IFN-γ/IL4 ratio. (I) IFN-γ/IL10 ratio. Two-tailed unpaired Student’s t-test (compared with Naïve group): (*), P<0.05; (***), P<0.0001. (A-I) Error bars indicate S.E.M. of triplicate determinations.